SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 12, 2017
MEDICAL INNOVATION HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
|(State or Other Jurisdiction||(Commission||(I.R.S. Employer|
|of Incorporation)||File Number)||Identification No.)|
5805 State Bridge Road, Suite G-328, Duluth, Georgia 30097
(Address of Principal Executive Offices) (Zip Code)
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|[ ]||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|[ ]||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|[ ]||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|[ ]||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
SECTION 7 — REGULATION FD DISCLOSURE
Item 7.01 Regulation FD Disclosure .
The information in this Item 7.01 of this Current Report is furnished pursuant to Item 7.01 and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act regardless of any general incorporation language in such filing.
On October 12, 2017 Medical Innovation Holdings Inc. issued a press release. The text of the press release in its entirety is attached herewith as Exhibit 99.1.
SECTION 8 — OTHER EVENTS
Item 8.01 Other Events
On September 28, 2017, the Company retained Hart & Hart, LLC, of Denver, Colorado, as the Company’s corporate and securities counsel.
SECTION 9 — FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statements and Exhibits.
The following is a complete list of exhibits filed as part of this Report.
Exhibit numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|Medical Innovation Holdings, Inc.|
|By:||/s/ Arturo Jake Sanchez|
Arturo “Jake” Sanchez
Date: October 12, 2017
Medical Innovation Holdings, Inc. (MIHI) Launches Spanish-Language Telemedicos USA
Telemedicos USA telemedicine platform provides 24/7 access to Spanish-speaking physicians and specialists, including discounts, medications, alternative medications, laboratory services, and risk shared health coverage programs
DULUTH, GEORGIA (October 12, 2017) Medical Innovation Holdings, Inc. (MIHI) today announces the launch of Telemedicos USA ( www.TelemedicosUSA.com ), a Spanish-language health care platform positioned to address the needs of the 58 million Hispanics in the United States.
Hispanics are the largest minority group in the country, and represent the majority of U.S. millennials. By connecting with this demographic, while also serving its older generations, MIHI is positioned to accommodate the needs of this group long term.
Additionally, the Hispanic population has a high incidence of diabetes and overweight individuals, revealing the long-term need for MIHI to establish itself as the leader in telemedicine-based programs for this group. Telemedicos USA provides the opportunity for MIHI to deliver its specialty services to a market of considerable size, and to those who prefer the Spanish language.
“This was a natural evolution for us. We purposefully positioned MIHI for this market because we understand the nuances of providing services to such an ethnically diverse group that make up the Hispanic community. We have a Mexican-American CEO, two of our three board members are Hispanic (Mexican American and Colombian), and some of our largest shareholders are Panamanian, Puerto Rican and Cuban. We know the Hispanic community, and the community knows us,” states MIHI CEO Jake Sanchez.
Telemedicos USA will use primary care, on-demand telemedicine services paired with 3PointCare’s specialty network of doctors providing unparalleled access to health care. In addition, Telemedicos USA will offer pharmaceuticals, alternative medicines, and patient portals to create an electronic medical record (EMR) cloud-based that travels with the patient. With these features, Telemedicos USA can provide the nation’s Hispanic population access to a doctor wherever they are.
About Medical Innovation Holdings, Inc.
Medical Innovation Holdings, Inc. (MIHI) owns and operates strategically aligned health care service companies focused on the delivery of clinical virtual medicine (health) to bring quality medical care to all areas of need, including rural and underdeveloped areas across the country. Through its wholly owned 3Point Care subsidiary, MIHI provides personalized high-tech telemedicine encounters pairing the company’s virtual health specialty doctors and traditional primary doctors that utilize next-gen virtual health technologies to connect a patient with a multi-disciplinary specialty clinical health care practice. Through its other companies and partnerships, MIHI offers Affordable Care Organization (ACO) support, wellness and prevention, lab analysis and lab services, and remote diagnostic monitoring.
We serve a number of constituents and stakeholders interested in reducing the cost of care, enhancing the quality of care, promoting access to care, and maintaining the continuum of care.
For more information, visit http://www.MedicalInnovationHoldings.com
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov .
Medical Innovation Holdings
New York, New York